Connect Biopharma Holdings Limited
Stock Forecast, Prediction & Price Target

Connect Biopharma Holdings Limited Financial Estimates

Connect Biopharma Holdings Limited Revenue Estimates

Connect Biopharma Holdings Limited EBITDA Estimates

Connect Biopharma Holdings Limited Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $251.98M
Low: $150.00M
High: $353.90M
avg. 0%
Avg: $203.90M
Low: $157.06M
High: $250.74M
avg. -19.08%
Avg: $333.32M
Low: $256.75M
High: $409.88M
avg. 63.46%
Avg: $400.94M
Low: $308.83M
High: $493.03M
avg. 20.28%
Net Income
 
% change YoY
$-1.30B
 
N/A
$-797.05M
 
39.00%
$-59.50M
 
92.53%
Avg: $-432.42M
Low: $-297.58M
High: $-278.74M
avg. -626.72%
Avg: $-560.40M
Low: $-497.57M
High: $-268.73M
avg. -29.59%
Avg: $-133.96M
Low: $-173.96M
High: $-93.95M
avg. 76.09%
Avg: $-116.56M
Low: $-151.36M
High: $-81.74M
avg. 12.99%
EBITDA
 
% change YoY
$-1.30B
 
N/A
$-762.06M
 
41.60%
$-58.37M
 
92.34%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$25.05
 
N/A
-$14.5
 
42.11%
-$1.08
 
92.55%
Avg: -$5.24
Low: -$5.41
High: -$5.07
avg. -385.39%
Avg: -$6.97
Low: -$9.05
High: -$4.89
avg. -32.97%
Avg: -$2.44
Low: -$3.16
High: -$1.71
avg. 65.03%
Avg: -$2.12
Low: -$2.75
High: -$1.49
avg. 12.99%
Operating Expenses
 
% change YoY
$621.47M
 
N/A
$785.21M
 
26.34%
$62.07M
 
-92.09%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Connect Biopharma Holdings Limited stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -141.80% in 2025-2028.

We have gathered data from 2 analysts. Their low estimate is -297.58M, average is -432.42M and high is -278.74M.

What is Connect Biopharma Holdings Limited stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 16.16% in 2025-2028.

We have gathered data from 2 analysts. Their low revenue estimate is $150.00M, average is $251.98M and high is $353.90M.

What is Connect Biopharma Holdings Limited stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -85.08% in 2025-2028.

We have gathered data from 2 analysts. Their low earnings per share estimate is -$5.41, average is -$5.24 and high is $-5.07.

What is the best performing analyst?

In the last twelve months analysts have been covering Connect Biopharma Holdings Limited stock. The most successful analyst is Louise Chen.